Anavex Life Sciences Corp (AVXL)

[Doktornolittle]

I hope that the extension of the phase 2AB would not necessitate a delay of the 2BA; and I don't think it would. Particularly if you believe the extension is really at the request of the patients and givers. Hearing it from the Australian doc, I do believe it.

While not slowing the trials, that extension would increase the odds of an early marketing approval, providing further safety and efficacy data both.

Wondering what your estimate is for the number of warrants remaining ipulator, but won't ask you to show your cards. Wondering if the SP hung in the 62-65 range yesterday due to a planned sell of the 30 cent warrants at a 2-bagger minimum. If so, then perhaps expect the same ranging at a little over 2 x 40 cents. Curious what percent of volume you attribute to warrants while you watch such ranging, but again, I won't ask.

Or were the 30s gone long before yesterday?